nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgements
|
|
|
2011 |
|
1 |
p. 59-59 |
artikel |
2 |
A review of the medical treatment of primary sclerosing cholangitis in the 21st century
|
Goode, Elizabeth C. |
|
2016 |
|
1 |
p. 68-85 |
artikel |
3 |
Asenapine in bipolar I disorder: evidence and place in patient management
|
Samalin, Ludovic |
|
2013 |
|
1 |
p. 5-14 |
artikel |
4 |
Belimumab in systemic lupus erythematosus: an update for clinicians
|
Kim, Susan S. |
|
2012 |
|
1 |
p. 11-23 |
artikel |
5 |
Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C
|
Cortez, Karoll J. |
|
2015 |
|
1 |
p. 4-14 |
artikel |
6 |
Bilateral chylothorax: an unusual complication of cervical rib resection
|
Morjaria, Jaymin B. |
|
2015 |
|
1 |
p. 29-33 |
artikel |
7 |
Developments in rare bone diseases and mineral disorders
|
Bacon, Siobhan |
|
2018 |
|
1 |
p. 51-60 |
artikel |
8 |
Editorial
|
Schachter, Michael |
|
2010 |
|
1 |
p. 5-6 |
artikel |
9 |
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
|
George, Leena |
|
2016 |
|
1 |
p. 34-51 |
artikel |
10 |
Eplerenone: is it time to add this drug to current heart failure therapy?
|
Pitt, Bertram |
|
2012 |
|
1 |
p. 5-9 |
artikel |
11 |
Ezetimibe: an update on its clinical usefulness in specific patient groups
|
Hammersley, Daniel |
|
2017 |
|
1 |
p. 4-11 |
artikel |
12 |
Flibanserin for hypoactive sexual desire disorder: place in therapy
|
Gelman, Faina |
|
2017 |
|
1 |
p. 16-25 |
artikel |
13 |
Glaucoma management: relative value and place in therapy of available drug treatments
|
Sambhara, Deepak |
|
2014 |
|
1 |
p. 30-43 |
artikel |
14 |
Glucocorticoid-induced osteoporosis: how best to avoid fractures
|
Cooper, Mark S. |
|
2010 |
|
1 |
p. 17-23 |
artikel |
15 |
Indacaterol in chronic obstructive pulmonary disease: an update for clinicians
|
Yorgancioglu, Arzu |
|
2012 |
|
1 |
p. 25-36 |
artikel |
16 |
Killing two birds with one stone: successful opioid monotherapy in intractable migraine-triggered epilepsy, a case series
|
Derakhshan, Iraj |
|
2017 |
|
1 |
p. 12-15 |
artikel |
17 |
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness
|
Anderson, Sarah L. |
|
2016 |
|
1 |
p. 4-17 |
artikel |
18 |
Looking at the causes of, and possible treatments for, psychiatric diseases: gene-environment interactions, circadian rhythms and neuronal dysfunction
|
Mallarkey, Gordon |
|
2011 |
|
1 |
p. 5-8 |
artikel |
19 |
Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential
|
Røder, Michael E. |
|
2018 |
|
1 |
p. 33-50 |
artikel |
20 |
Management of functional dyspepsia: state of the art and emerging therapies
|
Yamawaki, Hiroshi |
|
2018 |
|
1 |
p. 23-32 |
artikel |
21 |
New anticoagulants in atrial fibrillation: an update for clinicians
|
Bhusri, Satjit |
|
2012 |
|
1 |
p. 37-45 |
artikel |
22 |
New findings in osteoarthritis pathogenesis: therapeutic implications
|
Pulsatelli, Lia |
|
2013 |
|
1 |
p. 23-43 |
artikel |
23 |
Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management
|
Ackerman, Stacey |
|
2016 |
|
1 |
p. 52-67 |
artikel |
24 |
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
|
D’Ambrosio, Daniele |
|
2016 |
|
1 |
p. 18-33 |
artikel |
25 |
Radiation-induced small bowel disease: latest developments and clinical guidance
|
Stacey, Rhodri |
|
2014 |
|
1 |
p. 15-29 |
artikel |
26 |
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy
|
Jeffery, Douglas R. |
|
2013 |
|
1 |
p. 45-51 |
artikel |
27 |
Review: Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials
|
Rejnmark, Lars |
|
2011 |
|
1 |
p. 25-37 |
artikel |
28 |
Review: Frontiers in Alzheimer’s disease therapeutics
|
Stone, Jeremy G. |
|
2011 |
|
1 |
p. 9-23 |
artikel |
29 |
Review: Montelukast in asthma: a review of its efficacy and place in therapy
|
Paggiaro, Pierluigi |
|
2011 |
|
1 |
p. 47-58 |
artikel |
30 |
Review: Pegylated interferon and ribavirin treatment for hepatitis C virus infection
|
Palumbo, Emilio |
|
2011 |
|
1 |
p. 39-45 |
artikel |
31 |
Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
|
Frieder, Jillian |
|
2018 |
|
1 |
p. 5-21 |
artikel |
32 |
The future role of gut hormones in the treatment of obesity
|
Troke, Rachel C. |
|
2014 |
|
1 |
p. 4-14 |
artikel |
33 |
The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease
|
O'Connor, Anthony |
|
2010 |
|
1 |
p. 7-16 |
artikel |
34 |
Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy
|
Kaneko, Atsushi |
|
2013 |
|
1 |
p. 15-21 |
artikel |
35 |
Treatment of painful diabetic neuropathy
|
Javed, Saad |
|
2015 |
|
1 |
p. 15-28 |
artikel |